ALIAS

Albumin in Acute Stroke Trial: A study to ascertain whether high-dose human albumin therapy confers neuroprotection in acute ischemic stroke over and above best standard of care (specifically, to determine whether albumin therapy increases the proportion of acute ischemic stroke patients with favorable outcome compared to placebo therapy at 3 months from randomization)

IRIS Trial

Insulin Resistance Intervention after Stroke (IRIS) Trial: A randomized clinical trial that will test the effectiveness of a new treatment (pioglitazone) for preventing future strokes and heart attacks among persons with a recent stroke or TIA

PRoFESS Trial

Prevention Regimen For Effectively avoiding Second Strokes: A double-blind, active and placebo controlled study of Aggrenox® vs. clopidogrel, with and without Micardis®

RESPECT Trial

Randomized evaluation of recurrent stroke comparing PFO closure to established current standard of care treatment

Premium Trial

Prospective randomized investigation to evaluate incidence of headache reduction in subjects with migraine and PFO using the AMPLATZER PFO Occluder compared to medical management

TUSCON Trial

To provide information regarding the safety, tolerability, and activity in promoting recanalization (at 90 minutes) of escalating doses of MRX-801 accompanied by continuous ultrasound in conjunction with treatment with tPA in subjects with acute ischemic stroke

For more information on the ALIAS clinical trial, please contact:
Mary Brethour, CRNP
Office: 205.975.7574

For more information on the IRIS clinical trial, please contact:
Silvia Wybert, RN
Office: 205.996.7944

For more information on the RESPECT clinical trial, please contact:
Mary Brethour, CRNP
Office: 205.975.7574

For more information on the MERCI registry, please contact:
Mary Brethour, CRNP
Office: 205.975.7574